Cancer Prevention Research · 2011 · 53 citations · 40 references
MedicineEndocrinologyUrologyCancer PreventionProstate DiseaseSteroid BiochemistryProstate CancerVitamin DVitamin D DeficiencyVitamin D MetabolismVitamin D NutritionVitamin PhysiologyDietary Vitamin D IntakeNutritional Vitamin D StatusProstate FunctionProstate Intraepithelial NeoplasiaSerum 25-Hydroxyvitamin D StatusVitamin D PhysiologyVitamin D ReceptorsVitamin D Status Biomarkers
Low vitamin D (VD) status may increase prostate cancer risk but experimental evidence for this relationship is modest. We tested whether low VD status or VD receptor (VDR) deletion influences prostate epithelial cell (PEC) biology using intact mice, castrated mice, or castrated mice treated with testosterone propionate (TP, 2.5 mg/kg BW). PEC proliferation (Ki-67 staining) and apoptosis (TUNEL method) were determined in the anterior prostate (AP). In study 1, wild-type (WT) and TgAPT(121) mice (a model of prostate intraepithelial neoplasia) were fed diets with 25, 200 (reference diet), or 10,000 IU VD/kg diet (as vitamin D(3)) prior to castration/repletion. Serum 25 hydroxyvitamin D levels were 26, 78, and 237 nmol/L in the three diet groups, respectively. Castration reduced proliferation and increased apoptosis in the AP while TP reversed these effects. Low VD diet increased proliferation in WT (+82%) and TgAPT(121) (+24%) mice while it suppressed apoptosis in WT (-29%) and TgAPT(121) (-37%) mice. This diet also increased the severity of prostate intraepithelial neoplastic lesions in the AP of intact TgAPT(121) mice. In study 2, mice with PEC-specific VDR deletion (PEC VDR KO) were examined after castration/repletion. TUNEL staining was 60% lower in castrated PEC VDR KO mice compared with castrated WT mice. In castrated mice given TP, Ki-67 staining was 2-fold higher in PEC VDR KO compared with WT mice. Our data show that low diet VDR or VDR deletion provide a prostate environment that is permissive to early procarcinogenic events that enhance prostate cancer risk.
40
Philip G. Reeves, Forrest H. Nielsen, G. C. Fahey · Journal of Nutrition · 1993 · 8.7K citations
Héctor G. Pálmer, José Manuel González‐Sancho, Jesús Espada et al. · The Journal of Cell Biology · 2001 · 801 citations · Full text
Medicine, Oncology, Pharmacology +16
Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)
Merja Ahonen, Leena Tenkanen, L Teppo et al. · Cancer Causes & Control · 2000 · 490 citations
Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells.
D.M. Peehl, Roman Skowroński, Gordon Leung et al. · PubMed · 1994 · 478 citations